KIFC1 and neoplasm: Targeting KIFC1 could significantly enhance the lethality of chemotherapeutic drugs for tumor cells [9], whose underlying mechanisms may involve centrosome de-cluster [10], energy metabolism [11] and endoplasmic reticulum dysfunction [5].